My Quote Request
6505-01-284-5150
20 Products
NDC00172-2982-60
CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE CAPSULES
NSN, MFG P/N
6505012845150
NSN
6505-01-284-5150
NDC00172-2982-60
CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE CAPSULES
NSN, MFG P/N
6505012845150
NSN
6505-01-284-5150
MFG
ZENITH LABORATORIES INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 5.000 MILLIGRAMS CHLORDIAZEPOXIDE HYDROCHLORIDE ACTIVE INGREDIENT AND 2.500 MILLIGRAMS CLIDINIUM BROMIDE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: ACTIVE MEDICAMENT MEDICINAL STRENGTH:5.000 MILLIGRAMS OF CHLORDIAZEPOXIDE ACTIVE INGREDIENTS
Related Searches:
NDC18393-0272-02
NAPROXEN TABLETS,USP
NSN, MFG P/N
6505012840271
NSN
6505-01-284-0271
NDC18393-0272-02
NAPROXEN TABLETS,USP
NSN, MFG P/N
6505012840271
NSN
6505-01-284-0271
MFG
SYNTEX LABORATORIES INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 250.000 MILLIGRAMS NAPROXEN ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 60.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: UNIT OF USE
Related Searches:
1192
LIDOCAINE HYDROCHLORIDE INJECTION,USP
NSN, MFG P/N
6505012840272
NSN
6505-01-284-0272
1192
LIDOCAINE HYDROCHLORIDE INJECTION,USP
NSN, MFG P/N
6505012840272
NSN
6505-01-284-0272
MFG
INTERNATIONAL MEDICATION SYSTEMS LTD.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.000 PERCENTAGE, W/V LIDOCAINE HYDROCHLORIDE ACTIVE INGREDIENT
ADMINISTRATION: INTRACARDIAL
FEATURES PROVIDED: STERILE
PRIMARY CONTAINER CONTENT QUANTITY: 5.000 MILLILITERS
PRIMARY CONTAINER TYPE: SYRINGE WITH NEEDLE
SPECIAL FEATURES: EACH SYRINGE CONTAINS 50 MG. LIDOCAINE HYDROCHLORIDE; NEEDLE SIZE 21 GAGE BY 1-1/2 INCHES; WITHOUT EPINEPHARINE
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
NDC00548-1192-00
LIDOCAINE HYDROCHLORIDE INJECTION,USP
NSN, MFG P/N
6505012840272
NSN
6505-01-284-0272
NDC00548-1192-00
LIDOCAINE HYDROCHLORIDE INJECTION,USP
NSN, MFG P/N
6505012840272
NSN
6505-01-284-0272
MFG
INTERNATIONAL MEDICATION SYSTEMS LTD.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.000 PERCENTAGE, W/V LIDOCAINE HYDROCHLORIDE ACTIVE INGREDIENT
ADMINISTRATION: INTRACARDIAL
FEATURES PROVIDED: STERILE
PRIMARY CONTAINER CONTENT QUANTITY: 5.000 MILLILITERS
PRIMARY CONTAINER TYPE: SYRINGE WITH NEEDLE
SPECIAL FEATURES: EACH SYRINGE CONTAINS 50 MG. LIDOCAINE HYDROCHLORIDE; NEEDLE SIZE 21 GAGE BY 1-1/2 INCHES; WITHOUT EPINEPHARINE
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
NDC00486-1125-05
POTASSIUM PHOSPHATE,MONOBASIC,TABLETS
NSN, MFG P/N
6505012841136
NSN
6505-01-284-1136
NDC00486-1125-05
POTASSIUM PHOSPHATE,MONOBASIC,TABLETS
NSN, MFG P/N
6505012841136
NSN
6505-01-284-1136
MFG
BEACH PRODUCTS INC DBA BEACH PHARMACEUTICALS
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 852.000 MILLIGRAMS POTASSIUM PHOSPHATE, MONOBASIC ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
000768
DIFLORASONE DIACETATE CREAM,USP
NSN, MFG P/N
6505012841138
NSN
6505-01-284-1138
000768
DIFLORASONE DIACETATE CREAM,USP
NSN, MFG P/N
6505012841138
NSN
6505-01-284-1138
MFG
ALLERGAN INC
Description
ACTIVE INGREDIENT AND STRENGTH: 0.050 DIFLORASONE DIACETATE PERCENTAGE, W/W
PRIMARY CONTAINER CONTENT QUANTITY: 60.000 GRAMS
PRIMARY CONTAINER TYPE: TUBE, COLLAPSIBLE
Related Searches:
NDC00023-0766-60
DIFLORASONE DIACETATE CREAM,USP
NSN, MFG P/N
6505012841138
NSN
6505-01-284-1138
NDC00023-0766-60
DIFLORASONE DIACETATE CREAM,USP
NSN, MFG P/N
6505012841138
NSN
6505-01-284-1138
MFG
ALLERGAN INC
Description
ACTIVE INGREDIENT AND STRENGTH: 0.050 DIFLORASONE DIACETATE PERCENTAGE, W/W
PRIMARY CONTAINER CONTENT QUANTITY: 60.000 GRAMS
PRIMARY CONTAINER TYPE: TUBE, COLLAPSIBLE
Related Searches:
309530
CLOTRIMAZOLE TROCHES
NSN, MFG P/N
6505012841650
NSN
6505-01-284-1650
MFG
BAYER PHARMACEUTICALS CORPORATION
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 MILLIGRAMS CLOTRIMAZOLE ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 14.000 TROCHES
PRIMARY CONTAINER TYPE: STRIP
TOTAL PRIMARY CONTAINER QUANTITY: 5
Related Searches:
MYCELEX
CLOTRIMAZOLE TROCHES
NSN, MFG P/N
6505012841650
NSN
6505-01-284-1650
MFG
BAYER PHARMACEUTICALS CORPORATION
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 MILLIGRAMS CLOTRIMAZOLE ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 14.000 TROCHES
PRIMARY CONTAINER TYPE: STRIP
TOTAL PRIMARY CONTAINER QUANTITY: 5
Related Searches:
NDC00026-3095-38
CLOTRIMAZOLE TROCHES
NSN, MFG P/N
6505012841650
NSN
6505-01-284-1650
NDC00026-3095-38
CLOTRIMAZOLE TROCHES
NSN, MFG P/N
6505012841650
NSN
6505-01-284-1650
MFG
BAYER PHARMACEUTICALS CORPORATION
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 MILLIGRAMS CLOTRIMAZOLE ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 14.000 TROCHES
PRIMARY CONTAINER TYPE: STRIP
TOTAL PRIMARY CONTAINER QUANTITY: 5
Related Searches:
NDC00469-1710-60
FLUOROURACIL INJECTION,USP
NSN, MFG P/N
6505012841651
NSN
6505-01-284-1651
NDC00469-1710-60
FLUOROURACIL INJECTION,USP
NSN, MFG P/N
6505012841651
NSN
6505-01-284-1651
MFG
LYPHOMED INC DIV OF FUJISAWA USA INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 50.000 MILLIGRAMS FLUOROURACIL ACTIVE INGREDIENT
ADMINISTRATION: INTRAVENOUS
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 50.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: PRESERVATIVE FREE
Related Searches:
4HT-2DU
HEMODIALYSIS SOLUTION SET,CONCENTRATED
NSN, MFG P/N
6505012842683
NSN
6505-01-284-2683
4HT-2DU
HEMODIALYSIS SOLUTION SET,CONCENTRATED
NSN, MFG P/N
6505012842683
NSN
6505-01-284-2683
MFG
BICARBOLYTE VIRGINIA INC
Description
COMPONENT BREAKDOWN WITHIN EACH TEST KIT: 10 1 GAL CONTAINER PART A,4;1 GAL CONTAINERS PART B,6;
SPECIAL FEATURES: EACH SET PROVIDES FOUR 4-HOUR TREATMENTS; EACH TREATMENT CONSISTS OF 2.0 GM. PER LITER OF DEXTROSE AND THE FOLLOWING MEQ. PER LITER OF IONS,SODIUM 139.0,POTASSIUM 2.0,CALCIUM 3.5,MAGNESIUM 1.5,ACETATE 4.0,BICARBONATE 35.0,AND CHLORINE 111.0
Related Searches:
MONOCLATE
ANTIHEMOPHILIC FACTOR,USP
NSN, MFG P/N
6505012842948
NSN
6505-01-284-2948
MFG
ARMOUR PHARMACEUTICAL CO DIV OF RHONE-POULENC RORER INC
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ANTIHEMOPHILIC FACTOR USP LYOPHILIZED FORM FACTOR VIII:C HUMAN
PHYSICAL FORM: FREEZE-DRIED POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 INTERNATIONAL UNITS OF ACTIVE INGREDIENT
PRIMARY CONTAINER TYPE: VIAL, SINGLE DOSE
SPECIAL FEATURES: FACTOR VIII:C HUMAN;HEAT TREATED,AND/OR SOLUTION/DETERGENT CONCENTRATE;EACH VIAL PACKAGED W/SUFFICIENT DILUENT,STERILE FILTER NEEDLE AND ONE WINGED INFUSION SET;1 VIAL
Related Searches:
NDC00053-7656-04
ANTIHEMOPHILIC FACTOR,USP
NSN, MFG P/N
6505012842948
NSN
6505-01-284-2948
NDC00053-7656-04
ANTIHEMOPHILIC FACTOR,USP
NSN, MFG P/N
6505012842948
NSN
6505-01-284-2948
MFG
CSL BEHRING L.L.C.
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ANTIHEMOPHILIC FACTOR USP LYOPHILIZED FORM FACTOR VIII:C HUMAN
PHYSICAL FORM: FREEZE-DRIED POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 INTERNATIONAL UNITS OF ACTIVE INGREDIENT
PRIMARY CONTAINER TYPE: VIAL, SINGLE DOSE
SPECIAL FEATURES: FACTOR VIII:C HUMAN;HEAT TREATED,AND/OR SOLUTION/DETERGENT CONCENTRATE;EACH VIAL PACKAGED W/SUFFICIENT DILUENT,STERILE FILTER NEEDLE AND ONE WINGED INFUSION SET;1 VIAL
Related Searches:
NDC00053-7658-04
ANTIHEMOPHILIC FACTOR,USP
NSN, MFG P/N
6505012842948
NSN
6505-01-284-2948
NDC00053-7658-04
ANTIHEMOPHILIC FACTOR,USP
NSN, MFG P/N
6505012842948
NSN
6505-01-284-2948
MFG
ARMOUR PHARMACEUTICAL CO DIV OF RHONE-POULENC RORER INC
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ANTIHEMOPHILIC FACTOR USP LYOPHILIZED FORM FACTOR VIII:C HUMAN
PHYSICAL FORM: FREEZE-DRIED POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 INTERNATIONAL UNITS OF ACTIVE INGREDIENT
PRIMARY CONTAINER TYPE: VIAL, SINGLE DOSE
SPECIAL FEATURES: FACTOR VIII:C HUMAN;HEAT TREATED,AND/OR SOLUTION/DETERGENT CONCENTRATE;EACH VIAL PACKAGED W/SUFFICIENT DILUENT,STERILE FILTER NEEDLE AND ONE WINGED INFUSION SET;1 VIAL
Related Searches:
IMOVAX
RABIES VACCINE,USP
NSN, MFG P/N
6505012842949
NSN
6505-01-284-2949
MFG
SANOFI PASTEUR INC.
Description
III EXTERIOR CONTAINER WEIGHT: 28.50 POUNDS
III PART NAME ASSIGNED BY CONTROLLING AGENCY: RABIES VACCINE HUMAN DIPLOID CELL STRAIN SYRINGE-NEEDLE UNIT
III PROTECTIVE STORAGE FEATURE: REQUIRES REFRIGERATION BETWEEN 2 DEG TO 8 DEG C AND SUBJECT TO DAMAGE BY FREEZING
III UNIT OF ISSUE CUBE: 0.0088 CUBIC FEET
IMMEDIATE CONTAINER QUANTITY: 1
IMMEDIATE CONTAINER TYPE: SYRINGE-NEEDLE UNIT
QUANTITY WITHIN EACH IMMEDIATE CONTAINER: 1 UNIT DOSE
SPECIAL FEATURES: PACKAGE CONTAINS ONE SINGLE-DOSE DISPOSABLE SYRINGE WITH INTEGRAL NEEDLE,0.25 I.U. OF LYOPHILIZED VACCINE,AND ONE VIAL OF STERILE WATER FOR INJECTION IN SUFFICIENT QUANTITY FOR RECONSTITUTION; FOR PRE-EXPOSURE INTRADERMAL USE ONLY
UNIT PACKAGE QUANTITY: 1
UNIT PACKAGE TYPE: PACKAGE
Related Searches:
IMOVAX RABIES ID VACCINE
RABIES VACCINE,USP
NSN, MFG P/N
6505012842949
NSN
6505-01-284-2949
IMOVAX RABIES ID VACCINE
RABIES VACCINE,USP
NSN, MFG P/N
6505012842949
NSN
6505-01-284-2949
MFG
SANOFI PASTEUR INC.
Description
III EXTERIOR CONTAINER WEIGHT: 28.50 POUNDS
III PART NAME ASSIGNED BY CONTROLLING AGENCY: RABIES VACCINE HUMAN DIPLOID CELL STRAIN SYRINGE-NEEDLE UNIT
III PROTECTIVE STORAGE FEATURE: REQUIRES REFRIGERATION BETWEEN 2 DEG TO 8 DEG C AND SUBJECT TO DAMAGE BY FREEZING
III UNIT OF ISSUE CUBE: 0.0088 CUBIC FEET
IMMEDIATE CONTAINER QUANTITY: 1
IMMEDIATE CONTAINER TYPE: SYRINGE-NEEDLE UNIT
QUANTITY WITHIN EACH IMMEDIATE CONTAINER: 1 UNIT DOSE
SPECIAL FEATURES: PACKAGE CONTAINS ONE SINGLE-DOSE DISPOSABLE SYRINGE WITH INTEGRAL NEEDLE,0.25 I.U. OF LYOPHILIZED VACCINE,AND ONE VIAL OF STERILE WATER FOR INJECTION IN SUFFICIENT QUANTITY FOR RECONSTITUTION; FOR PRE-EXPOSURE INTRADERMAL USE ONLY
UNIT PACKAGE QUANTITY: 1
UNIT PACKAGE TYPE: PACKAGE
Related Searches:
NDC49281-0251-20
RABIES VACCINE,USP
NSN, MFG P/N
6505012842949
NSN
6505-01-284-2949
MFG
SANOFI PASTEUR INC.
Description
III EXTERIOR CONTAINER WEIGHT: 28.50 POUNDS
III PART NAME ASSIGNED BY CONTROLLING AGENCY: RABIES VACCINE HUMAN DIPLOID CELL STRAIN SYRINGE-NEEDLE UNIT
III PROTECTIVE STORAGE FEATURE: REQUIRES REFRIGERATION BETWEEN 2 DEG TO 8 DEG C AND SUBJECT TO DAMAGE BY FREEZING
III UNIT OF ISSUE CUBE: 0.0088 CUBIC FEET
IMMEDIATE CONTAINER QUANTITY: 1
IMMEDIATE CONTAINER TYPE: SYRINGE-NEEDLE UNIT
QUANTITY WITHIN EACH IMMEDIATE CONTAINER: 1 UNIT DOSE
SPECIAL FEATURES: PACKAGE CONTAINS ONE SINGLE-DOSE DISPOSABLE SYRINGE WITH INTEGRAL NEEDLE,0.25 I.U. OF LYOPHILIZED VACCINE,AND ONE VIAL OF STERILE WATER FOR INJECTION IN SUFFICIENT QUANTITY FOR RECONSTITUTION; FOR PRE-EXPOSURE INTRADERMAL USE ONLY
UNIT PACKAGE QUANTITY: 1
UNIT PACKAGE TYPE: PACKAGE
Related Searches:
NAPROSYN TABLETS
NAPROXEN TABLETS,USP
NSN, MFG P/N
6505012844453
NSN
6505-01-284-4453
NAPROSYN TABLETS
NAPROXEN TABLETS,USP
NSN, MFG P/N
6505012844453
NSN
6505-01-284-4453
MFG
SYNTEX LABORATORIES INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 375.000 MILLIGRAMS NAPROXEN ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 60.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: UNIT OF USE
Related Searches:
NDC18393-0273-02
NAPROXEN TABLETS,USP
NSN, MFG P/N
6505012844453
NSN
6505-01-284-4453
NDC18393-0273-02
NAPROXEN TABLETS,USP
NSN, MFG P/N
6505012844453
NSN
6505-01-284-4453
MFG
SYNTEX LABORATORIES INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 375.000 MILLIGRAMS NAPROXEN ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 60.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: UNIT OF USE